Dr Giulia Detela is Quality Manager at VivaBioCell S.p.A., a company acquired by NantWorks in 2015 which develops automated systems for cell and tissue engineering therapy. VivaBioCell S.p.A pipeline comprises GMP-in-a-box platforms and CE-marked biomaterials for osteoarthritis therapy and bone regeneration including dental and maxillofacial applications.
Giulia was previously a Process Development Scientist at The Cell and Gene Therapy Catapult, supporting the development of novel candidate advanced therapy products and associated CMC quality requirements for multiple clients and collaborators within industry, academia and NHS. She obtained her PhD with a project aimed at discovering strategies to enhance the engraftment and angiogenic potential of human mesenchymal stromal cells within ischemic tissues at the Regenerative Medicine and Bioprocessing Unit of the Department of Biochemical Engineering at University College London (UCL), where she further worked as a Research Assistant. Giulia graduated at the University of Trieste, Italy, with a Master's degree in Functional Genomics.